Super bread? study tests carob & germ recipe for better blood sugar

NCT ID NCT06200272

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study tested whether whole-wheat bread enriched with carob molasses pulp and germ can improve blood sugar response and antioxidant capacity in healthy adults. Twenty volunteers aged 19-35 ate both standard and enriched breads, and their blood was tested over three hours. The goal is to see if this bread could help prevent chronic diseases like diabetes and obesity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
whole-wheat bread enriched with carob molasses pulp and germ
What this could lead to
If results are positive, this could point toward a healthier bread option that helps manage blood sugar and boost antioxidants, potentially reducing chronic disease risk.
What could go wrong
This is a very small, early study in only 20 healthy people. It does not test long-term effects or disease outcomes, so findings may not apply to the general population or those with health conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Dec 2023

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 35 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * no acute or chronic disease * no prescription drugs and/or nutritional supplements * no pregnant or lactating * no alcohol or excessive alcohol consumption (\<2 drinks/day) * no smoking, * BMI value between 18.5-24.9 kg/m2 * no in the menstrual period for female individuals * no gluten enteropathy * no insulin resistance as a result of endocrinological examination and biochemical tests * no allergic reaction to carob * signed the Informed Volunteer Consent Form * aged between 19 and 35 years. Exclusion Criteria: * having an acute or chronic disease * using prescription drugs and/or nutritional supplements * being in pregnancy and lactation * consuming excessive alcohol (\>2 drinks/day) * smoking * BMI value under 18.5 or above 24.9. kg/m2 * being in the menstrual period for female individuals * having gluten enteropathy * having insulin resistance as a result of endocrinological examination and biochemical tests * having an allergic reaction to carob * not signed the Informed Volunteer Form, * aged under 19 years or above 35 years of age

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy participants are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Toros University

    Mersin, Yenişehir, 33140, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.